|
|
|
|
|
|||||||
|
Session 56
Poster Session
Acute Infection: Resistance, Fitness, and Transmission 4:30-6:30 pm 4E-F |
to view the poster for an abstract.| 365-M. | Relationship between Seminal and Plasma Viral Loads among Persons with Primary HIV Infection J. Kahn*1, F. Hecht1, M. Warmerdam2, L. Liu1, and R. M. Grant1 1Univ. of California, San Francisco and 2Gladstone Inst. of Virology and Immunology, San Francisco, CA
| ||
| 366-M. | Estimating Transmission Probabilities over Time in Acute HIV Infection from Biological Data C. Pilcher*1, H. Tien1, P. Stewart1, P. Vernazza2, H. Chakraborty3, J. J. Eron1, and M. Cohen1 1Univ. of North Carolina, Chapel Hill; 2Univ. Hosp., St. Gallen, Switzerland; and 3Emory Univ., Atlanta, GA
| ||
| 367-M. | Will Transmission of Drug Resistant HIV be Driven by Individuals Infected with Drug Resistant Strains? A. J. Leigh Brown*1,2, S. D. W. Frost1, W. C. Mathews1, N. S. Hellmann3, E. S. Daar4, D. D. Richman1, and S. J. Little1 1Univ. of California, San Diego; 2Univ. of Edinburgh, UK; 3ViroLogic, Inc., South San Francisco, CA; and 4Univ. of California, Los Angeles
| ||
| 368-M. | Transmission and Transmissibility of Drug Resistant HIV-1 R. M. Grant*1,2, J. Kahn2, M. Warmerdam1, L. Liu2, C. J. Petropoulos3, N. S. Hellmann3, and F. Hecht2. 1Gladstone Inst. of Virology and Immunology, San Francisco, CA; 2Univ. of California, San Francisco; and 3ViroLogic, Inc., South San Francisco, CA
| ||
| 369-M. | Survey of Genotypic Drug Resistance and Molecular Epidemiology of Virus from Patients with HIV-1 Primary Infection in 2000 in France M. L. Chaix*1, D. Descamps2, M. Harzic3, V. Schneider4, C. Deveau5, I. Pellegrin6, C. Tamalet7, B. Masquelier6, C. Rouzioux1, L. Meyer5, F. Brun-Vezinet2, and D. Costagliola8 for the ANRS AC11 Resistance Group Cohort PRIMO and PRIMSTOP Study Groups 1Hosp. Necker, Paris; 2Hosp. Bichat, Paris; 3Hosp. Versailles; 4Hosp. Rotschild, Paris; 5INSERM U292, Kremlin-Bicêtre; 6Hosp. Pellegrin, Bordeaux; 7Hosp. La Timone Marseille; and 8SC4 INSERM, Paris, France
| ||
| 370-M. | No Increase in Protease Resistance and a Decrease in Reverse Transcriptase Resistance Mutations in Primary HIV-1 Infection: 1992-2001 Sydney, Australia P. Ammaranond*1, P. Cunningham2, R. Oelrichs3, K. Suzuki1, C. Harris2 , L. Leas2, A. Grulich1, A. D. Kelleher1, and D. A. Cooper1 1NCHECR, Univ. of New South Wales, Sydney; 2St. Vincent's Hosp., Univ. of New South Wales, Sydney; and 3Macfarlane Burnet Ctr. for Med. Res., Fairfield, Australia
| ||
| 371-M. | Decline in the Rate of Genotypic Resistance to Antiretroviral Drugs in Recent HIV Seroconverters in Spain C. de Mendoza1, J. del Romero2, C. Rodríguez2, A. Corral1, and V. Soriano*1 1Inst. de Salud Carlos III and 2Ctr. Sandoval, Madrid, Spain
| ||
| 372-M. | Prevalence of Mutations Associated with Antiretroviral Drug Resistance among Recently Diagnosed Persons with HIV, 1998-2000 D. Bennett *, I. Zaidi, W. Heneine, T. Woods, G. García-Lerma, J. Kaplan, H. Weinstock for the Sentinel Surveillance for Variant, and Drug-Resistant Strains of HIV Study (SSVRS) Teams CDC, Atlanta, GA
| ||
| 373-M. | Prevalence of HIV-1 Drug-Transmitted Resistance in Semen of Patients on HAART with Acute Sexually Transmitted Infections S. Taylor*1,3, T. Sadiq2, S. Kaye2, J. Workman1, P. Cane1, J. Bennet2, R. Johnstone2, P. Byrne2, A. Copas 2, S. Drake3, I. Weller2, and D. Pillay1 1PHLS, Univ. of Birmingham; 2Royal Free and Univ. Coll. Med. Sch., London; and 3Birmngham Heartlands Hosp., UK
| ||
| 374-M. | Identification of a Transmission Chain of Drug-Resistant HIV-1 S. Taylor*1,2, P. Cane1 , J. Workman1, S. Drake2, M. Shamanesh3, and D. Pillay1 1PHLS, Univ. of Birmingham; 2Birmingham Heartlands Hosp.; and 3Whittle Street Clin., Birminghham, UK
| ||
| 375-M. | First Report of Multi-Drug Resistant HIV-1 in Southern Africa S. Miller*, D. Peters, and L. Keena Innovir Inst., Johannesburg, South Africa
| ||
| 376-M. | Infectivity and in Vitro Replication of Sexually Transmitted Drug-Resistant HIV-1 Variants V. Simon*, J. Vanderhoeven, A. Hurley, H. Mizuno, N. Padte, A. Horowitz, and M. Markowitz Aaron Diamond AIDS Res. Ctr., Rockefeller Univ., New York, NY
| ||
| 377-M. | Replicative Fitness of MDR Viruses in Primary HIV-1 Infection M. Petrella*, B. Brenner, J. P. Routy, D. Moisi, M. Oliveira, M. Detorio, B. Spira, B. Conway, R. Lalonde, R. P. Sekaly, and M. A. Wainberg McGill AIDS Ctr., Lady Davis Inst., Montreal, QC, Canada
| ||
| 378-M. | Memory CD4+ T Cells Are the Earliest Detectable HIV-1-Infected Cells in the Female Genital Mucosal Tissue during HIV-1 Transmission in an Organ Culture System P. Gupta*1, K. Collins1, D. Dampf1, D. Landers1, G. Naus1, and B. Patterson2 1Univ. of Pittsburgh, PA and 2Northwestern Univ., Chicago, IL
| ||
| 379-M. | Recovery of Infectious Human Immunodeficiency Virus Type-1 (HIV-1) from the Oropharynx: Implications for Oral Transmission of HIV-1 C. Celum1, T. K. Collis1, W. Whittington1, J. Sanchez2, A. Lucchetti2, D. Lockhart1, D. Dithmer-Schreck1, R. Zuckerman1, R. Sampoleo1, S. Harb1, J. Dragavon1, and R. W. Coombs*1 1Univ. of Washington, Seattle and 2Impacta Salud y Educacion, Lima, Peru
|
